Topic
Psychedelics
90 published works
Budding Trends
Tell Me What You Want, What You Really, Really Want: FDA’s Top Officials Put Their Psychedelics Position in Writing
By Hillary Campbell, James H. Torbert
As the Spice Girls taught us in the nineties, it’s a lot easier if you tell me what you want, what you really, really want. Last month, the Food and…
RF EMerge
FDA Guidance, Clinical Pipelines, and the Emerging Deal Landscape of Psychedelic Therapeutics
By Aydin H. Harston, Michael Ellenberger, Stephanie Waltersdorff
Introduction Psychedelic drug development is moving from a largely experimental field toward a suddenly much more compelling pharmaceutical industry, with a rapidly expanding clinical pipeline that now includes multiple late-stage…
Budding Trends
Trip Advisor: FDA Publishes Guidance on Psychedelic Drug Trials
By Slates C. Veazey, Hillary Campbell
We've been waiting on this one for three years. If you've frequented this blog, you know three years is basically an eternity in Food and Drug Administration (FDA) years but…
Budding Trends
The States Take the Wheel: A Roundup of Recent State Action on Psychedelics in the South
At some point over the course of each year, we like to take stock of where psychedelics stand — our own version of a trip around the sun. The story…
Budding Trends
What the Marijuana Rescheduling Order Means for Psychedelics
This is the last of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends…
Budding Trends
Is the Trump Administration All in on Psychedelics?
The Trump administration's interest in psychedelics as medicine has continued to come into focus over the past several weeks, with two developments suggesting that momentum at the federal level continues…
Budding Trends
Cannabis Day: Top 10 Weed Roundup of Budding Trends’ Trendiest Blog Posts of the Year
By Whitt Steineker, Slates C. Veazey, Stephen McCluskey, Hillary Campbell, Rachel L. Sodée, Anne Snell
Here at Budding Trends, we like to roll up our “Top 10 Weed Roundup” between the sacred and renowned 420 holidays. Each year, we pack a recap post with 10…
Bill of Health
Regulating Psilocybin as Food, Not Drugs
By Erin Lynch
Psychedelics Regulating Psilocybin as Food, Not Drugs Psilocybin should be regulated under food law rather than drug law. Doing so would serve public health, individual autonomy, and regulatory coherence. Published…
Bill of Health
States, Not the FDA, Are Winning the Drug War
By Erin Lynch
Psychedelics States, Not the FDA, Are Winning the Drug War President Trump’s recent executive order directing federal agencies to finalize the rescheduling of cannabis from Schedule I to Schedule III marks a…
The Healthcare Investor
What’s Next in the Psychedelics Market, With Matt Brockmeier and Rebecca Nicholson
https://player.captivate.fm/episode/825d67d1-38f7-4dd1-8617-1d92d0748c49 A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at…